LAMB2 and cancer: Challenges with the CAM-Delam method might be to examine non-GFP cancer cell lines, which requires relevant antibodies to identify the investigated cancer cells, and to score cancer cell lines that express high levels of laminin, which can, but does not have to be a disadvantage, to determine morphological changes of the basal lamina.